Table 5. Cost–effectiveness of childhood rotavirus vaccination, Norway, 2015–2019.
Perspective | Cost–effectiveness outcome | Rotarix® Mean (€) |
RotaTeq® Mean (€) |
---|---|---|---|
Healthcare | Cost per QALY loss avoided | 47 447 | 52 709 |
Cost per case avoided | 70 | 77 | |
Cost per hospitalised case avoided | 1150 | 1278 | |
Societal | Savings per QALY loss avoided | 187 784 | 182 552 |
Savings per case avoided | 275 | 268 | |
Savings per hospitalised case avoided | 4 553 | 4 426 |